Contact information
Emma Culver
BSc (Hons), MBChB, MRCP, DPhil
Consultant Hepatologist & Senior Lecturer in Gastroenterology & Hepatology, JR Hospital, Oxford.
- Wellcome Trust Clinical Research Fellow, University of Oxford, Oxford, UK.
Emma Culver is a Consultant Hepatologist and Senior Lecturer at the Translational Gastroenterology Unit, John Radcliffe Hospital in Oxford, with an interest in immune mediated liver diseases including IgG4-related disease, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis.
She set up and co-ordinated the IgG4-RD Study in Oxford during her Academic Clinical Fellowship (2010) and Wellcome Trust Clinical Research Fellowship (DPhil 2011-2015). Her PhD work focussed on the natural history and immunological drivers of IgG4-RD. Her NIHR BRC Oxford Clinical Lectureship (2018-) centred on the fibrotic mechanisms of this disease. She runs the Oxford Autoimmune Liver Disease service with specialist IgG4, PSC and autoimmune liver clinics, and runs a regional autoimmune liver disease MDT, and a national Oxford-London IgG4 MDT.
She is Chair of UK IgG4 and on the Steering Committee for UK PSC, and a member of the International IgG4-RD, PSC and AIH Study Groups.
Recent publications
-
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
Journal article
Perugino C. et al, (2023), Rheumatology and therapy
-
Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study.
Journal article
Eder P. et al, (2023), Journal of Crohn's & colitis
-
IgG4-related disease
Journal article
Nwaduru C. and Culver EL., (2023), Medicine (United Kingdom), 51, 405 - 411
-
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
Journal article
Abbas N. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 21, 1561 - 1570.e13
-
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.
Journal article
Liao W. et al, (2023), EClinicalMedicine, 59